1218.74 The Carolina Trial

Investigator: Mahendra Jain, MD

Study Coordinator: Bela Jain

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT01243424

Phone: 281.485.3434

IRB Number: Pro00010400

Description

The aim of the study is to investigate the longterm impact on cardiovascular morbidity and mortality, relevant efficacy parameters (e.g., glycaemic parameters) and safety (e.g., weight and hypoglycaemia) of treatment with linagliptin in patients with type 2 diabetes at elevated cardiovascular risk receiving usual care, and compare outcome against glimepiride.
More to Explore